GE HealthCare Technologies Inc (GEHC) concluded trading on Thursday at a closing price of $72.91, with 3.45 million shares of worth about $251.31 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -14.62% during that period and on May 15, 2025 the price saw a gain of about 0.10%. Currently the company’s common shares owned by public are about 457.84M shares, out of which, 456.67M shares are available for trading.
Stock saw a price change of 3.42% in past 5 days and over the past one month there was a price change of 15.55%. Year-to-date (YTD), GEHC shares are showing a performance of -6.74% which decreased to -10.02% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $57.65 but also hit the highest price of $94.80 during that period. The average intraday trading volume for GE HealthCare Technologies Inc shares is 5.03 million. The stock is currently trading 6.52% above its 20-day simple moving average (SMA20), while that difference is down -0.04% for SMA50 and it goes to -11.82% lower than SMA200.
GE HealthCare Technologies Inc (NASDAQ: GEHC) currently have 457.84M outstanding shares and institutions hold larger chunk of about 82.46% of that.
The stock has a current market capitalization of $33.38B and its 3Y-monthly beta is at 1.34. PE ratio of stock for trailing 12 months is 15.33, while it has posted earnings per share of $4.76 in the same period. Its PEG reads 2.91 and has Quick Ratio of 0.72 while making debt-to-equity ratio of 1.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GEHC, volatility over the week remained 3.04% while standing at 3.23% over the month.
Analysts are in expectations that GE HealthCare Technologies Inc (GEHC) stock would likely to be making an EPS of 0.92 in the current quarter, while forecast for next quarter EPS is 0.93 and it is 4.56 for next year. For the current quarter EPS, analysts have given the company a lowest target 0.85 which is 0.96 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of 1.0 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -10.08% while it is estimated to increase by 13.85% in next year. EPS is likely to shrink at an annualized rate of 5.26% for next 5-years, compared to annual growth of 5.31% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by UBS on May 05, 2025 offering a Neutral rating for the stock and assigned a target price of $73 to it. Coverage by Goldman stated GE HealthCare Technologies Inc (GEHC) stock as a Buy in their note to investors on March 11, 2025, suggesting a price target of $100 for the stock. On January 08, 2025, Jefferies Upgrade their recommendations, while on September 26, 2024, UBS Downgrade their ratings for the stock with a price target of $74. Stock get a Buy rating from BTIG Research on September 18, 2024.
